Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy.

Takayuki Uemura,Masatoshi Nishimoto,Masahiro Eriguchi,Hiroyuki Tamaki,Hikari Tasaki,Riri Furuyama,Fumihiro Fukata,Takaaki Kosugi,Katsuhiko Morimoto,Masaru Matsui,Ken-Ichi Samejima,Kazuhiko Tsuruya

Diabetes, obesity & metabolism（2023）

引用 0|浏览8

暂无评分

摘要

Among patients with biopsy-proven DN, serum β2-MG was an independent predictor of KFRT and improved prediction performance. In addition to serum creatinine, serum β2-MG should probably be measured for DN.

查看译文

关键词

kidney

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要